Percutaneous intervention on the saphenous vein bypass grafts - Long-term outcomes

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 1, 2008, Pages 58-61

  Bansal, Darpan ^a,b   Muppidi, Raghu ^a,b   Singla, Sandeep ^a,b   Sukhija, Rishi ^a,b   Zarich, Stuart ^c   Mehta, Jawahar L ^a,b   Sachdeva, Rajesh ^a,b,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c BRIDGEPORT HOSPITAL   (United States)

^d Department of Medicine ^*  (United States)

Author keywords

Drug eluting stent; Outcome; Percutaneous intervention; Saphenous vein graft

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LONG TERM CARE; MALE; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; LOGISTIC MODELS; MIDDLE AGED; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS; TREATMENT OUTCOME;

EID: 38549096087     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21413     Document Type: Article

References (11)

1. Fitzgibbon G, Kafka H, Leach A, et al. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
2. Peykar S, Angiolillo DJ, Bass TA, et al. Saphenous vein graft disease. Minerva Cardioangiol 2004;52:379-390.
3. Plokker HW, Meester BH, Serruys PW. The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. Am J Cardiol 1991;67:361-366.
4. de Jaegere PP, van Domburg RT, Feyter PJ, et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996;28:89-96.
5. Lee MS, Shah AP, Aragon J, et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 2005;66:507-511.
6. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern. Circulation 2007;115:1440-1455.
7. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: A meta-analysis. Eur Heart J 2006;27: 2784-2814.
8. Chu WW, Rha SW, Kuchulakanti PK, et al. Efficacy of Sirolimus eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006;97:34-37.
9. Vermeersch P, Agostoni P, Verheye S, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: Six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 2006;48:2423-2431.
10. Ge L, Iakovou I, Sangiorgi G, et al. Treatment of saphenous vein graft lesions with drug eluting stents. J Am Coll Cardiol 2005;45:989-994.
11. Paul Vermeersch, Pierfrancesco Agostoni, Stefan Verheye, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol 2007;50:261-267.